0
Your cart

Your cart is empty

Browse All departments
  • All departments
Price
  • R1,000 - R2,500 (8)
  • R2,500 - R5,000 (21)
  • R5,000 - R10,000 (10)
  • -
Status
Brand

Showing 1 - 25 of 39 matches in All departments

Combined Modality Therapy of Central Nervous System Tumors (Paperback, Softcover reprint of the original 1st ed. 2003):... Combined Modality Therapy of Central Nervous System Tumors (Paperback, Softcover reprint of the original 1st ed. 2003)
Zbigniew Petrovich; Foreword by L.W. Brady; Edited by Luther W. Brady; Foreword by H.-P. Heilmann, M. Molls; Edited by …
R3,787 Discovery Miles 37 870 Ships in 7 - 11 working days

The American Cancer Society anticipates that 16,500 patients will be diagnosed with primary malignant tumors of the central nervous system in 2000, with about 200,000 individuals presenting with brain metastases. The advances in the treatment of solid tumors have contributed significantly to the major increase in metastatic cancers to the brain. Of the primary malignant tumors of the brain, more than 50% are high-grade gliomas; the incidence has been increasing among older patients over the past decade. Major developments in new technologies in the treatment of primary brain tumors as well as metastatic disease are covered in depth. Even though management is difficult, advances are being made. This book is a concerted effort to present data regarding basic science research efforts alongside their translation into clinical practice using combined, integrated multimodal programs of treatment. Progress has been made, but innovatice approaches need to be pursued.

Radiation Oncology for Cure and Palliation (Hardcover, 2003 ed.): L.W. Brady Radiation Oncology for Cure and Palliation (Hardcover, 2003 ed.)
L.W. Brady; R.G. Parker; Preface by S.M. Mellinkoff; N.A. Janjan; Foreword by H.-P. Heilmann; …
R4,738 R3,769 Discovery Miles 37 690 Save R969 (20%) Ships in 10 - 15 working days

Given that treatment with curative intent is possible in only one-half of cancer victims, and that such treatment frequently fails, the majority of patients with cancer will require relief of symptoms and signs caused by their disease. In this book, the specific contribution of radiation therapy to palliation is considered within the context of multidisciplinary management. Individual chapters are devoted to palliative radiation therapy for primary tumours and metastases at different sites. The management of pain is discussed, and chapters are also devoted to end of life care, the management of complications of radiation therapy, and useful medications. This book will prove useful and interesting not only to radiation oncologists but also to medical students of all ages and to doctors from all disciplines who are concerned with the relief or prevention of suffering in patients with cancer.

Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy - A Clinical Guide to Cancer Treatment... Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy - A Clinical Guide to Cancer Treatment (Paperback, Softcover reprint of the original 1st ed. 2004)
L.W. Brady; Preface by H. Suit; Edited by Vincent Gregoire; Foreword by H.-P. Heilmann; Edited by Pierre Scalliet; Foreword by …
R4,266 R3,554 Discovery Miles 35 540 Save R712 (17%) Ships in 10 - 15 working days

Conformal radiation therapy represents a new challenge for radiation oncologists. It offers the prospect of either increasing the radiation dose to target tissues while delivering a similar dose to organs at risk, or reducing the dose to organs at risk while maintaining the dose to target tissues. First, lymph node areas at risk are established using the available data from pathological examination of surgical specimens and/or pattern of locoregional relapse. Then, based on a three-dimensional description of the anatomical regions where the areas at risk are located, guidelines for the delineation of the clinical target volumes are proposed. The data presented should enable the reader to make appropriate decisions regarding the selection and delineation of the target volumes when confronted with the most frequent tumor types and sites.The book will contribute to paving the way for more effective radiation oncology in the twenty-first century.

Radiotherapy for Non-Malignant Disorders (Paperback, Softcover reprint of hardcover 1st ed. 2008): Michael Heinrich... Radiotherapy for Non-Malignant Disorders (Paperback, Softcover reprint of hardcover 1st ed. 2008)
Michael Heinrich Seegenschmiedt; Foreword by L.W. Brady, H.-P. Heilmann; Edited by Hans-Bruno Makoski, Klaus-Rudiger Trott; Foreword by …
R7,524 Discovery Miles 75 240 Ships in 7 - 11 working days

This volume discusses the background and various clinical applications of radiation therapy in the treatment of non-malignant diseases. It documents the radiobiological and physical principles of treatment and the rationale underlying the use of radiotherapy for various disorders of the CNS, head and neck, eye, skin and soft tissues, bone and joints, and vascular system. In so doing, it draws attention to and elucidates the scope for application of radiotherapy beyond the treatment of malignancies. Both the risks and the benefits of such treatment are fully considered, the former ranging from minor clinical problems to life-threatening diseases.

Carcinoma of the Bladder - Innovations in Management (Paperback, Softcover reprint of the original 1st ed. 1998): L.W. Brady Carcinoma of the Bladder - Innovations in Management (Paperback, Softcover reprint of the original 1st ed. 1998)
L.W. Brady; Preface by D.G. Skinner; Edited by Zbigniew Petrovich, Luc Baert; Foreword by H.-P. Heilmann; Edited by …
R2,770 R2,417 Discovery Miles 24 170 Save R353 (13%) Ships in 10 - 15 working days

Concentrating on the diagnosis and treatment of carcinoma of the bladder, rather than the entire field of genitourinary oncology, this book discusses in depth all the important advances in molecular genetics of relevance to clinical practice. Progress in both imaging and non-imaging modalities from recent clinical trials is well documented and critically evaluated in a manner that will prove invaluable for practising urooncologists. Furthermore, the management of patients with superficial, muscle-invasive, and advanced disease is discussed, and new treatment results presented. Numerous illustrations and tables serve to assist in understanding the data presented.

Spezielle Strahlentherapie Maligner Tumoren Teil 5 / Radiation Therapy of Malignant Tumours Part 5 (German, Paperback,... Spezielle Strahlentherapie Maligner Tumoren Teil 5 / Radiation Therapy of Malignant Tumours Part 5 (German, Paperback, Softcover Reprint of the Original 1st 1984 ed.)
H. Bunemann; Contributions by H.-P. Heilmann; H. Frommhold, H.-P. Heilmann, H Roesler, …
R1,817 R1,592 Discovery Miles 15 920 Save R225 (12%) Ships in 10 - 15 working days

Die Strahlentherapie der otorhinolaryngologischen Tumoren sowie der Tumoren des Re- spirationstraktes stellt eine der wichtigsten Aufgaben des Radioonkologen dar. Er ist hier wesentlicher Partner im Rahmen der interdisziplinaren Onkologie und betreut gemeinsam mit dem Otorhinolaryngologen, dem Chirurgen oder Pulmologen die Patienten. In einzelnen Bereichen, so beim kleinzelligen Bronchus-Karzinom, ist eine enge Koopera- tion zwischen medizinischer Onkologie und Radioonkologie Voraussetzung einer sinnvollen Behandlung. Eine umfassende Darstellung der strahlentherapeutischen Moglichkeiten im Rahmen des Gesamtbildes der Erkrankungen der HNO-Tumoren-und der Tumoren des Respirationstrak- tes bildet damit ein wertvolles Hilfsmittel flir jeden Arzt, der mit der Behandlung dieser Tumoren befaBt ist. Die radiologischen Moglichkeiten in der Behandlung der malignen Schilddriisentumoren stellen ein Thema dar, bei dem besonders dringend eine fachkundige zusammenfassende Darstellung erforderlich wurde. Auch dieses Kapitel wird nicht nur dem Radioonkologen, sondern anderen, mit den Erkrankungen der Schilddriise befaBten Arzten eine wertvolle Hilfe sein. Hamburg H.-P. HElLMANN Preface Radiotherapy of otorhinolaryngolic tumors and tumors of the respiratory tract is one of the most important responsibilities of radio-oncologists. They are major partners in inter- disziplinary oncology and treat patients together with otorhinolaryngologists, surgeons, and pulmologists. In special problems, such as small-cell bronchial carcinoma, close cooperation between radio-oncologists and medical-oncologists is a precondition of meaningful treatment. The possible applications of radiology in treating malignant thyroid tumors also require a compre- hensive expert discussion.

Radiation Oncology of Gynecological Cancers (Paperback, Softcover reprint of the original 1st ed. 1997): L.W. Brady Radiation Oncology of Gynecological Cancers (Paperback, Softcover reprint of the original 1st ed. 1997)
L.W. Brady; Edited by Helmut W. Vahrson; Foreword by H.-P. Heilmann
R2,461 Discovery Miles 24 610 Ships in 7 - 11 working days

A comprehensive description of the current treatment modalities, and while special attention is paid to the role of radiotherapy, established alternative radical surgical procedures and the newer chemotherapeutic regimens are also considered in detail. Devoted entirely to female genital cancers, the book is written by internationally recognised experts from Europe, the United States, and Japan, who all have extensive experience of the special entities involved. Close to 200 tables present the impressive amount of data contributed by the authors in a clear manner and no attempt is made to avoid controversies concerning adequate treatment.

Multimodal Concepts for Integration of Cytotoxic Drugs (Hardcover, 2006 ed.): Martin J. Brown Multimodal Concepts for Integration of Cytotoxic Drugs (Hardcover, 2006 ed.)
Martin J. Brown; Foreword by L.W. Brady; Edited by M. P. Mehta; Foreword by H.-P. Heilmann, M. Molls; Edited by …
R5,960 Discovery Miles 59 600 Out of stock

Over recent decades, combined modality treatment has drastically improved the cure rates for various malignant tumors. Further progress is expected through the design of sound combinations involving recently developed drugs. The first part of this book summarizes the rationale and the preclinical data for combined treatment with ionizing radiation and pharmaceutical agents. Individual chapters focus on different forms of combined treatment, with due consideration being given to a range of drugs and to emerging combinations with small molecules and antibodies. The second part of the book comprises a series of disease-specific chapters in which the clinical results of combined modality treatment are presented. The text, written by acknowledged experts, is specifically designed to be accessible to professionals from the various disciplines involved in multidisciplinary cancer care and to residents in radiation oncology training programs.

Progress and Perspective in the Treatment of Lung Cancer (Paperback, Softcover reprint of the original 1st ed. 1999): Paul... Progress and Perspective in the Treatment of Lung Cancer (Paperback, Softcover reprint of the original 1st ed. 1999)
Paul Vanhoutte; Foreword by L.W. Brady, H.-P. Heilmann; Edited by J. Klastersky, P. Rocmans
R3,425 Discovery Miles 34 250 Out of stock

This volume provides a comprehensive account of the progress that has been made in the treatment of lung cancer. The various therapeutic approaches are documented and appraised, with particular emphasis being placed on the benefits of a multimodality strategy. A balance is sought between US and European perspectives, and all of the authors are recognized experts in the field.

Radiation Oncology for Cure and Palliation (Paperback, Softcover reprint of the original 1st ed. 2003): L.W. Brady Radiation Oncology for Cure and Palliation (Paperback, Softcover reprint of the original 1st ed. 2003)
L.W. Brady; R.G. Parker; Preface by S.M. Mellinkoff; N.A. Janjan; Foreword by H.-P. Heilmann; …
R5,255 Discovery Miles 52 550 Ships in 7 - 11 working days

Given that treatment with curative intent is possible in only one-half of cancer victims, and that such treatment frequently fails, the majority of patients with cancer will require relief of symptoms and signs caused by their disease. In this book, the specific contribution of radiation therapy to palliation is considered within the context of multidisciplinary management. Individual chapters are devoted to palliative radiation therapy for primary tumours and metastases at different sites. The management of pain is discussed, and chapters are also devoted to end of life care, the management of complications of radiation therapy, and useful medications. This book will prove useful to radiation oncologists and medical students.

Age-Related Macular Degeneration - Current Treatment Concepts (Paperback, Softcover reprint of the original 1st ed. 2001): L.W.... Age-Related Macular Degeneration - Current Treatment Concepts (Paperback, Softcover reprint of the original 1st ed. 2001)
L.W. Brady; Edited by W.E. Alberti, G. Richard; Foreword by H.-P. Heilmann, M. Molls; Edited by …
R2,990 Discovery Miles 29 900 Out of stock

Age-related macular degeneration (ARMD) is a frequent disease of the elderly and the most common cause of blindness. Recently, various new treatment options have become available for ARMD. This book, written by recognized experts and including the results of international study groups, provides a comprehensive report on these treatments, documenting their rationale, uses, side-effects, and benefits. It will be of immense value to all with an interest in ARMD.

Late Sequelae in Oncology (Paperback, Softcover reprint of the original 1st ed. 1995): L.W. Brady Late Sequelae in Oncology (Paperback, Softcover reprint of the original 1st ed. 1995)
L.W. Brady; Edited by Jurgen Dunst, Rolf Sauer; Foreword by H.-P. Heilmann
R3,446 Discovery Miles 34 460 Ships in 7 - 11 working days

Increasing survival figures and the use of more intense combined treatment regimens in modern oncology have raised the problem of late therapeutic sequelae in long-term survivors after cancer. Recent scientific approaches to late sequelae concentrate on the evaluation of subclinical changes with sophisticated functional measurements and experimental investigation of the underlying pathophysiological mechanisms.
The objective of the book is to bring together these recent clinical and experimental data from different medical disciplines to give an overview of the most relevant problems of late sequelae. In clinical practice the book may help regarding estimation of risks, selection of diagnostic methods, and estimation of the prognosis of late sequelae.

Age-Related Macular Degeneration - Current Treatment Concepts (Hardcover, 2001 ed.): L.W. Brady Age-Related Macular Degeneration - Current Treatment Concepts (Hardcover, 2001 ed.)
L.W. Brady; Edited by W.E. Alberti, G. Richard; Foreword by H.-P. Heilmann, M. Molls; Edited by …
R4,248 Discovery Miles 42 480 Out of stock

Age-related macular degeneration (ARMD) is a frequent disease of the elderly and the most common cause of blindness. Recently, various new treatment options have become available for ARMD. This book, written by recognized experts and including the results of international study groups, provides a comprehensive report on these treatments, documenting their rationale, uses, side-effects, and benefits. It will be of immense value to all with an interest in ARMD.

Mediastinal Tumors - Update 1995 (Paperback, Softcover reprint of the original 1st ed. 1995): L.W. Brady Mediastinal Tumors - Update 1995 (Paperback, Softcover reprint of the original 1st ed. 1995)
L.W. Brady; Edited by Douglas E. Wood; Contributions by M.S. Allen; Edited by Charles R., Jr. Thomas; Foreword by H.-P. Heilmann; Contributions by …
R2,962 Discovery Miles 29 620 Out of stock

Primary mediastinal tumors are relatively rare. The relative incidence of these tumors indicates that neurogenic tumors are the most common tumor seen constituting 21 % of all cases, thymomas 19%, lymphomas 12.5%, germ cell tumors 10%, primary carcinomas 4.6%, mesenchymal tumors 6%, endocrine tumors 6%, cysts 18%. In adults, the majority of thyroid tumors, thymomas, mediastinal germ cell tumors and teratomas are located in the superior and anterior mediastinum. Of the neurogenic tumors 18% are located in the posterior mediastinum, and 50% of mediastinal lymphomas are in the middle mediastinum. In adults, the incidence of anterosuperior, middle and posterior mediastinal tumors is about 54%, 20% and 26% respectively. However, in children the posterior mediastinum contains 63% of the lesions, the anterior mediastinum contains 26% and the middle mediastinum II %. The majority of the tumors are benign in character with a ratio of benign to malig nant of about 60 to 40. The relative incidence of malignant mediastinal tumors in children is about 50%. Even though mediastinal tumors are not common, they represent a unique problem with regards to treatment whether by surgery, radiation therapy and/or systemically administered chemotherapy. The volume by WOOD and THOMAS deals with each of these issues in detail and presents a logical and important approach to the management of mediastinal tumors.

Thermoradiotherapy and Thermochemotherapy - Volume 2: Clinical Applications (Paperback, Softcover reprint of the original 1st... Thermoradiotherapy and Thermochemotherapy - Volume 2: Clinical Applications (Paperback, Softcover reprint of the original 1st ed. 1996)
M. Heinrich Seegenschmiedt; Preface by L.W. Brady, H.-P. Heilmann; Edited by Peter Fessenden, Clare C. Vernon
R3,474 Discovery Miles 34 740 Out of stock

Hyperthermia has been found to be of great benefit in combination with radiation therapy or chemotherapy in the management of patients with difficult and com plicated tumor problems. It has been demonstrated to increase the efficacy of ionizing radiation when used locally but also has been of help in combination with systemic chemotherapy where hyperthermia is carried out to the total body. Triple modality (thermo-chemo-radiotherapy) or other treatment combinations have not been fully evaluated and may demonstrate extended clinical applications in the future. Problems remain with regard to maximizing the effects of hyperthermia as they are influenced by a variety of external and intrinsic factors including bloodflow, microenvironment etc. While the previous volume has summarized more theoretical aspects of hyper thermia, i.e. biology, physiology and physics, the present volume compiles the current knowledge relative to the clinical applications of hyperthermia in combina tion with radiation therapy and/or chemotherapy, providing a comprehensive over view of its use in cancer management.

Carcinoma of the Prostate - Innovations in Management (Paperback, Softcover reprint of the original 1st ed. 1996): L.W. Brady Carcinoma of the Prostate - Innovations in Management (Paperback, Softcover reprint of the original 1st ed. 1996)
L.W. Brady; Preface by D.G. Skinner; Edited by Zbigniew Petrovich, Luc Baert; Foreword by H.-P. Heilmann; Edited by …
R3,045 Discovery Miles 30 450 Out of stock

The American Cancer Society anticipates that during 1995, 244000 new cases of cancer of the prostate will have been diagnosed in the United States, with 40400 deaths from the disease process. The rapid increase in the actual number of new cases in the United States is directly related to more regularized digital rectal examinations and the more frequent and widespread use of prostate-specific antigen (PSA) screening programs. As a conse quence, major controversies have emerged in how best to manage the patient with cancer of the prostate. These include the necessity of PSA screening programs, how to interpret PSA values, what imaging studies are most appropriate for definition of the true extent of the disease process, the value of pretreatment surgical staging of the disease process, and the value of different treatments. The latter encompass a wide range of options: observa tion, radical prostatectomy, the Walsh-type prostatectomy procedure, definitive external beam radiation therapy, local interstitial implantation using iodine-125, iridium-l92, or palladium-103, orchiectomy, cryosurgery, hyperthermia, and various antitestosterone agents such as estrogens or LH,RH agonists. The present volume deals with the major parameters of controversy with regard to cancer of the prostate and will enable the reader to acquire a better understanding of the disease and how best it might be managed to achieve an optimal outcome with a minimum of complications.

Radiation Therapy Physics (Paperback, 1995 ed.): M.D. Altschuler Radiation Therapy Physics (Paperback, 1995 ed.)
M.D. Altschuler; Foreword by W. L. Brady; Edited by Alfred R. Smith; Foreword by H.-P. Heilmann; Contributions by P. Bloch, …
R3,311 Discovery Miles 33 110 Ships in 7 - 11 working days

The aim of this book is to provide a uniquely comprehensive source of information on the entire field of radiation therapy physics. The very significant advances in imaging, computational, and accelerator technologies receive full consideration, as do such topics as the dosimetry of radiolabeled antibodies and dose calculation models. The scope of the book and the expertise of the authors make it essential reading for interested physicians and physicists and for radiation dosimetrists.

Interstitial and Intracavitary Thermoradiotherapy (Paperback, Softcover reprint of the original 1st ed. 1993): L.W. Brady Interstitial and Intracavitary Thermoradiotherapy (Paperback, Softcover reprint of the original 1st ed. 1993)
L.W. Brady; Contributions by J. M Ardiet; Edited by M. Heinrich Seegenschmiedt; Foreword by H.-P. Heilmann; Contributions by L.V. Baert; Edited by …
R3,449 Discovery Miles 34 490 Out of stock

While hyperthermia has long been used within radiation oncology, the highly promising new techniques of interstitial and intracavitary hyperthermia are generally less well known. The considerable advantage of "internal" application of combined radiotherapy and hyperthermia is thata high degree of therapeutic efficacy can be achieved within a limited target volume while sparing surrounding structures from side-effects. It is therefore no surprise that the past decade has witnessed a dramatic increasein basic research into internal heating techniques, together with rapid technical development and expansion of clinical applications. This timely volume summarizes all essential biological aspects of heat interaction with radiotherapy, presents the technical state of the art, and analyzes the clinical results achieved with application of interstitial and intracavitary thermo-radiotherapy for tumors of a variety of sites. Treatment control and planning are given full consideration in a separate section, as too are special clinical applications. The final section discusses the design and performance of multicenter clinical trials. This book, written by recognized experts, will be of great valueto the theoretical researcher, the oncological practitioner, and specialistsin all related theoretical and clinical sciences of oncology.

Radiation Therapy in Pediatric Oncology (Paperback, Softcover reprint of the original 1st ed. 1994): L.W. Brady Radiation Therapy in Pediatric Oncology (Paperback, Softcover reprint of the original 1st ed. 1994)
L.W. Brady; Edited by J. Robert Cassady; Contributions by K.K. Ang; Foreword by H.-P. Heilmann; Contributions by J.A. Belli, …
R3,053 Discovery Miles 30 530 Out of stock

The diagnosis of cancer in a child is a devastating finding not only to the parents but often to the child. Even though the situation is relatively easy to accept among adults, it is difficult to accept among children because of their general helpless state. The advances that have been made in the management of a child with cancer in the last 20 years have been dramatic in character. These have occurred not only by virtue ofthe contributions from early diagnosis and more precise staging but also from the contribu tions made by surgery, radiation therapy, and the more widespread utilization of chemotherapy regimens. This volume by J. Robert Cassady sets forth the position of radiation oncology in the management of the child with cancer. Radiation therapy remains an important and significant part of the treatment of this group of diseases. The book presents the basic knowledge with regards to pediatric oncology and how it relates to radiation therapy. It gives a timely overview on the topic and is essential for all radiation oncologists involved in the management of children with cancer. Hamburg/Philadelphia, June 1994 H. -P. HEILMANN LUTHER W. BRADY Preface This book provides a thorough review of the role that radiation therapy currently plays in the management of most childhood tumors. Extensively augmented with figures and tables where appropriate, it also provides a concise review of current diagnostic and therapeutic approaches for major childhood malignancies. Extensive and up-to-date reference lists are an added benefit.

Interventional Radiation Therapy - Techniques - Brachytherapy (Paperback, Softcover reprint of the original 1st ed. 1991): L.W.... Interventional Radiation Therapy - Techniques - Brachytherapy (Paperback, Softcover reprint of the original 1st ed. 1991)
L.W. Brady; Edited by Rolf Sauer; Foreword by H.-P. Heilmann
R2,238 Discovery Miles 22 380 Out of stock

In the last decade brachytherapy experienced a dramatic up- swing. The introduction of new radioisotopes with favorable nuclear physical properties, computer-assisted dosimetry, and the advent of modified afterloading techniques set off this revolutionary development. The main topics discussed in this book are brain tumors and tumors of the head and neck, choroidal melanoma, breast cancer, carcinoma of the anal ca- nal, carcinoma of the prostate, and gynecological malignan- cies.

Practical Approaches to Cancer Invasion and Metastases - A Compendium of Radiation Oncologists' Responses to 40 Histories... Practical Approaches to Cancer Invasion and Metastases - A Compendium of Radiation Oncologists' Responses to 40 Histories (Paperback, Softcover reprint of the original 1st ed. 1994)
L.W. Brady; Contributions by B.S. Aron; Edited by A. Robert Kagan; Assisted by R.J. Steckel; Contributions by S.O. Asbell; Foreword by …
R2,966 Discovery Miles 29 660 Out of stock

In the United States in 1993 the American Cancer Society estimated that there were about 1,300,000 new cases of invasive cancer diagnosed. At the time of presentation about 70% of those patients represented limited local regional disease without evidences of distant dissemination. About 30% of the patients had demonstrated metastatic disease at the time of initial diagnosis or about 390,000 patients. Of those patients with local regional disease about 56% would be cured by the best treatment programs including surgery, radiation therapy with or without chemotherapy when given for cure. Therefore, of the 1,300,000 new cases of invasive cancer, about 509,000 would be cured by the best treatments available. However, about 790,000 patients will have metastatic disease as a part of initial presentation or following the completion of definitive treatment. The majority of the patients with metastatic disease will have metastases to bone as the dominant site of metastatic disease primarily from cancers of the breast and lung but other metastatic sites will be common including lung, liver, mediastinal and retro-peritoneallymph node groups as well as brain and spinal cord. It has been suggested by SMITHERS, CARLING and WINDEYER that the management of the patient with metastatic disease or recurrent disease can be a more difficult problem in management than a patient who is treated for cure.

Moglichkeiten und Grenzen der Antineoplastischen Therapie (German, Paperback, Softcover reprint of the original 1st ed. 1983):... Moglichkeiten und Grenzen der Antineoplastischen Therapie (German, Paperback, Softcover reprint of the original 1st ed. 1983)
K.P. Hellriegel, H. Sack; Contributions by K.W. Brunner, Franco Cavalli, H.-P. Heilmann, …
R1,405 Discovery Miles 14 050 Ships in 7 - 11 working days

H: SACK Lungentumoren sind die haufigste Krebstodesursache bei Mannern tiber 35 Jahren, die epidemiologischen Daten der letzten Jahre lassen erkennen, daB dies bald auch auf Frauen zutreffen wird. Zum Zeitpunkt der Diagnose hat das Bronchialkarzinom bei 70% der Patienten bereits Metastasen abgesiedelt, bei 22% in die regionalen Lymphknoten und bei 48% hamatogen. Das erkHirt, warum viele Patienten innerhalb des ersten Jahres nach Diagnosestellung versterben. Aber auch bei den Kranken mit einer klinisch lokalisierten Erkran- kung (17%) ist eine Oberlebenserwartun von 5 Jahren eher die Ausnahme als die Regel. Viele Hoffnungen wurden bei diesen Gegebenheiten auf die Friihdiagnose ge- setzt, urn den Tumor im loko-regional begrenzten Stadium der Operation zu- fUhren zu konnen, die fast allein als kurative BehandlungsmaBnahme anzuse- hen ist. Die Friihdiagnostik hat jedoch die in sie gesetzten Erwartungen nicht erftillen konnen. Feldstudien in den USA und der DDR haben eine Verbesse- rung der Oberlebensraten nicht erreichen konnen. Die Moglichkeiten der Friihdiagnose sind weiterhin beschrankt, Vorsorgeuntersuchungen fUr die Ge- samtbevolken, mg sind deshalb nicht empfehlenswert. Die folgenden Beitrage namhafter Forscher und Kliniker sollen den Stand des heute Moglichen in der Behandlung von Kranken mit Lungenkrebs diskutieren und Wege zur Verbesserung der Ergebnisse aufzeigen. Auch von den in kurati- ver Absicht radikal Operierten leben nach 5 Jahren nur rund 30%, nach 10 Jah- ren 15%. Die Operationsletalitat betragt je nach der GroBe des Eingriffs 4-11 %.

Combined Modality Therapy of Central Nervous System Tumors (Hardcover, 2003 ed.): Zbigniew Petrovich Combined Modality Therapy of Central Nervous System Tumors (Hardcover, 2003 ed.)
Zbigniew Petrovich; Foreword by L.W. Brady; Edited by Luther W. Brady; Foreword by H.-P. Heilmann, M. Molls; Edited by …
R4,889 Discovery Miles 48 890 Out of stock

The American Cancer Society anticipates that 16,500 patients will be diagnosed with primary malignant tumors of the central nervous system in 2000, with about 200,000 individuals presenting with brain metastases. The advances in the treatment of solid tumors have contributed significantly to the major increase in metastatic cancers to the brain. Of the primary malignant tumors of the brain, more than 50% are high-grade gliomas; the incidence has been increasing among older patients over the past decade. Major developments in new technologies in the treatment of primary brain tumors as well as metastatic disease are covered in depth. Even though management is difficult, advances are being made. This book is a concerted effort to present data regarding basic science research efforts alongside their translation into clinical practice using combined, integrated multimodal programs of treatment. Progress has been made, but innovatice approaches need to be pursued.

Thermoradiotherapy and Thermochemotherapy - Biology, Physiology, Physics (Hardcover, 1995 ed.): L.W. Brady Thermoradiotherapy and Thermochemotherapy - Biology, Physiology, Physics (Hardcover, 1995 ed.)
L.W. Brady; Contributions by J C Bolomey; Edited by M. Heinrich Seegenschmiedt; Foreword by H.-P. Heilmann; Edited by Peter Fessenden; Contributions by …
R8,049 Discovery Miles 80 490 Out of stock

Hyperthermia has been found to be of great benefit in combination with radiation therapy or chemotherapy in the management of patients with difficult and com plicated tumor problems. It has been demonstrated to increase the efficacy, of ionising radiation when used locally but also has been of help in combination with systemic chemotherapy where hyperthermia is carried out to the total body. Problems remain with regard to maximizing the effects of hyperthermia as in fluenced by blood flow, heat loss, etc. The present volume defines the current knowledge relative to hyperthermia with radiation therapy and/or chemotherapy, giving a comprehensive overview of its use in cancer management. Philadelphia/Hamburg, June 1995 L.W. BRADY H.-P. HEILMANN Preface In an attempt to overcome tumor resistance, hypoxia, or unfavorable tumor condi tions, oncological research has come to focus on gene therapy, immunotherapy, new cytotoxic agents, and increasingly sophisticated radiotherapy. Radiation research has been directed towards heavy particle therapy and modification of the radiation response by either protecting or sensitizing agents. Improved dose localization using rotational or conformal strategies has also been implemented. Recently, changes in radiation fractionation schedules have shown promise of better results. Hyperthermia in cancer therapy can be viewed similarly as another means to increase the sensitivity of tumors to radio- and chemotherapy.

Progress and Perspective in the Treatment of Lung Cancer (Hardcover, 1999 ed.): Paul Vanhoutte Progress and Perspective in the Treatment of Lung Cancer (Hardcover, 1999 ed.)
Paul Vanhoutte; Foreword by L.W. Brady, H.-P. Heilmann; Edited by J. Klastersky, P. Rocmans
R5,326 Discovery Miles 53 260 Out of stock

This volume provides a comprehensive account of the progress that has been made in the treatment of lung cancer. The various therapeutic approaches are documented and appraised, with particular emphasis being placed on the benefits of a multimodality strategy. A balance is sought between US and European perspectives, and all of the authors are recognized experts in the field.

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
Grand Theft Auto V: Premium Online…
R699 R576 Discovery Miles 5 760
Sylvanian Families - City House with…
 (31)
R2,171 R1,461 Discovery Miles 14 610
Lord You Are Good
Rebecca Malope CD R109 Discovery Miles 1 090
Crayola Erasable Twistable Pencil…
R100 Discovery Miles 1 000
Magic: The Gathering - Ikoria: Lair of…
R90 Discovery Miles 900
Not available
Audiomate SP8000p Bluetooth Speaker…
R549 R319 Discovery Miles 3 190
Lucky Supa - 3 Piece Plastic Comb Set…
R25 Discovery Miles 250
Marvel's Spider-Man: Miles Morales
R1,299 R1,187 Discovery Miles 11 870
Muscle Junkie Weight Ultimate Gym Gloves…
R249 Discovery Miles 2 490

 

Partners